首页> 外文期刊>JAMA: the Journal of the American Medical Association >Effect of On-Demand vs Routine Nebulization of Acetylcysteine With Salbutamol on Ventilator-Free Days in Intensive Care Unit Patients Receiving Invasive VentilationA Randomized Clinical Trial
【24h】

Effect of On-Demand vs Routine Nebulization of Acetylcysteine With Salbutamol on Ventilator-Free Days in Intensive Care Unit Patients Receiving Invasive VentilationA Randomized Clinical Trial

机译:按需对乙酰琥珀酸乙酰琥珀酸常规雾化的影响,含沙丁醇酰胺在呼吸机 - 护理单位患者接受侵袭性通风随机临床试验

获取原文
获取原文并翻译 | 示例
       

摘要

Importance It remains uncertain whether nebulization of mucolytics with bronchodilators should be applied for clinical indication or preventively in intensive care unit (ICU) patients receiving invasive ventilation. Objective To determine if a strategy that uses nebulization for clinical indication (on-demand) is noninferior to one that uses preventive (routine) nebulization. Design, Setting, and Participants Randomized clinical trial enrolling adult patients expected to need invasive ventilation for more than 24 hours at 7 ICUs in the Netherlands. Interventions On-demand nebulization of acetylcysteine or salbutamol (based on strict clinical indications, n?=?471) or routine nebulization of acetylcysteine with salbutamol (every 6 hours until end of invasive ventilation, n?=?473). Main Outcomes and Measures The primary outcome was the number of ventilator-free days at day 28, with a noninferiority margin for a difference between groups of ?0.5 days. Secondary outcomes included length of stay, mortality rates, occurrence of pulmonary complications, and adverse events. Results Nine hundred twenty-two patients (34% women; median age, 66 (interquartile range [IQR], 54-75 years) were enrolled and completed follow-up. At 28 days, patients in the on-demand group had a median 21 (IQR, 0-26) ventilator-free days, and patients in the routine group had a median 20 (IQR, 0-26) ventilator-free days (1-sided 95% CI, ?0.00003 to ∞). There was no significant difference in length of stay or mortality, or in the proportion of patients developing pulmonary complications, between the 2 groups. Adverse events (13.8% vs 29.3%; difference, ?15.5% [95% CI, ?20.7% to ?10.3%]; P ??.001) were more frequent with routine nebulization and mainly related to tachyarrhythmia (12.5% vs 25.9%; difference, ?13.4% [95% CI, ?18.4% to ?8.4%]; P ??.001) and agitation (0.2% vs 4.3%; difference, ?4.1% [95% CI, ?5.9% to ?2.2%]; P ??.001). Conclusions and Relevance Among ICU patients receiving invasive ventilation who were expected to not be extubated within 24 hours, on-demand compared with routine nebulization of acetylcysteine with salbutamol did not result in an inferior number of ventilator-free days. On-demand nebulization may be a reasonable alternative to routine nebulization. Trial Registration clinicaltrials.gov Identifier: NCT02159196
机译:重要性用支气管扩张黏液溶解剂的雾化是否应适用于临床适应症或预防在重症监护病房(ICU)接受有创通气患者尚不能确定。目的:确定一个策略,使用喷雾的临床适应症(按需)是劣于一个使用预防性的(常规)进行喷雾。设计,设置,和参与者随机临床试验招生的成人患者预计将需要超过24小时创通气在7个ICU在荷兰。干预点播乙酰半胱氨酸或沙丁胺醇雾化(基于严格的临床适应症,N'=?471)或与沙丁胺醇乙酰半胱氨酸的常规雾化(每6小时,直到有创通气的端中,n =?473)。主要成果和措施的主要成果是28天呼吸机的天数,与中〜0.5天群体之间的差异非劣性保证金。次要终点包括住院天数,死亡率,肺部并发症发生率和不良反应事件。结果九百22例(34%为女性;年龄中位数,66(四分位距[IQR],54-75年)参加并完成后续在第28天,患者按需组的中位21(IQR,0-26)自由呼吸机天,患者在常规组的中位20(IQR,0-26)自由呼吸机天(1双侧95%CI,?0.00003至∞)。有在逗留或死亡率,或用于患者的发展中的肺部并发症的比例的长度没有显著差异,两组之间的不良事件(13.8%比29.3%;?差,15.5%[95%CI,20.7%至10.3? %]; P<?001)用常规雾化更频繁,更主要涉及快速性心律失常(12.5%对25.9%;差,13.4%[95%CI,18.4%至8.4%〕; 2 P 2 <?001)和搅拌(0.2%对4.3%;差,4.1%[95%CI,5.9%至2.2%?]; P<?。001)结论和相关性在ICU患者在接受谁是预计在24小时内不被拔管创呼吸机,上要求C与沙丁胺醇乙酰半胱氨酸的常规喷雾ompared没有导致劣质一批呼吸机的日子。点播雾化可能是一个合理的替代程序进行喷雾。试验注册clinicaltrials.gov标识符:NCT02159196

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号